Our Sponsors
SCHEDULE
-
9:00 AM – 10:00 AM
-
10:00 AM – 10:15 AM
-
10:15 AM – 10:45 AM
Dr. Ethan Russo explores cannabigerol (CBG), an emerging focus in cannabis research, and its potential role in patient care. He will be sharing cutting edge new research in the field. Learn what the evidence suggests about its therapeutic promise, what questions remain, and why this lesser-known cannabinoid is drawing attention.
-
10:45 AM – 11:15 AM
Join Rep. Shelley Kloba for a check-in on Washington’s medical cannabis legislation and what it means for patients. We’ll explore recent developments, priorities for the next legislative session, and how patients’ lived experiences can inform lawmakers and shape meaningful change.
-
11:15 AM – 12:30 PM
With cannabis now in Schedule III, doors that were closed to researchers for decades are starting to open. This panel explores what rescheduling makes possible in Washington, from clinical studies and university research to the questions patients most want answered. We’ll look at what’s changing, what barriers remain, and how patients can help shape the research agenda.
Panel participants
Nephi Stella, PhD — Professor of Pharmacology and Psychiatry & Behavioral Sciences, University of Washington
Benjamin Land, PhD — Associate Professor of Pharmacology, University of Washington
Carrie Cuttler, PhD — Associate Professor of Psychology and Director of the Cannabis Research Center, Washington State University
Gregory T. Carter, MD, MS — Chief Medical Officer, Providence St. Luke’s Rehabilitation Medical Center
Drudys “Dru” Ledbetter, BSN, RN — Founder, MV Consulting
Jessica Tonani — Co-founder and CEO, Verda Bio
-
12:30 PM – 1:30 PM
-
1:30 PM – 2:45 PM
This conversation is why the Medical Cannabis Summit began: bringing patients and the Department of Health together to listen, learn, and address the realities of medical cannabis access. Patients will share their lived experiences, ask questions, and speak directly with regulators about what is working, where barriers remain, and what needs to change. Now in our fourth year, that direct dialogue remains at the heart of why we gather.
Department of Health participants
•Shannon Angell — Deputy Director, Center for Drug Systems, Data, and Science
•Annie Kause — Program Manager, Medical Cannabis Program
•Johnny Wong — Cannabis Scientist, Medical Cannabis Program
•Tholo “TJ” Johnson — Microbiologist 3, Medical Cannabis Program
•Loralei Walker — Medical Cannabis Program
•Bianca Rexroth — Health Services Consultant, Medical Cannabis Program
-
2:45 PM – 3:45 PM
How can patients advocate for themselves within the systems that shape their care and access to medical cannabis? This interactive town hall centers your questions and lived experiences, with advocates and healthcare professionals helping spark discussion about understanding your rights, navigating barriers, and finding support. Bring your experiences and ideas as we explore how to be heard and turn shared concerns into meaningful action.
Featuring Amanda Reiman, PhD, MSW — Founder, Personal Plants; and Steph Sherer — Founder, Executive Director, and Board President, Americans for Safe Access.
-
3:45 PM – 4:00 PM
Meet the Speakers
Ethan Russo, MD
Keynote speaker
Founder and CEO, CReDO Science
Ethan Russo is a board-certified neurologist, psychopharmacology researcher, and author. His work explores cannabis therapeutics, the endocannabinoid system, and interactions among cannabinoids and other plant compounds. He previously served as Senior Medical Advisor to GW Pharmaceuticals and is a past president of the International Cannabinoid Research Society.

Representative Shelley Kloba
Legislative Check-In
State Representative, 1st Legislative District
Washington House of Representatives
Shelley Kloba has served in the Washington House of Representatives since 2017. A former Kirkland City Councilmember and Washington State PTA Legislative Director, she works on consumer data privacy, public health, and cannabis policy, with a focus on patient access and clear standards for the industry.
Nephi Stella, PhD
Research Panel
Professor of Pharmacology and Psychiatry & Behavioral Sciences, University of Washington
Nephi Stella studies how cannabinoid signaling can be targeted to develop treatments for neurological diseases. His University of Washington laboratory investigates plant-derived, synthetic, and naturally occurring cannabinoids, with research focused on epilepsy, brain cancers, and the effects of cannabis on the developing brain.
Benjamin Land, PhD
Research Panel
Associate Professor of Pharmacology, University of Washington
Benjamin Land investigates how cannabinoids and opioids influence pain and reward. His laboratory studies their potential roles in chronic pain management and the associated risks of substance use disorder, using pharmacology, imaging, and biochemical approaches.
Carrie Cuttler, PhD
Research Panel
Associate Professor of Psychology and Director of the Cannabis Research Center, Washington State University
Carrie Cuttler directs Washington State University’s Cannabis Research Center and the Health & Cognition (THC) Lab. Her research examines the benefits and risks of cannabis and cannabinoids, including effects on memory and other cognitive functions, mental health, pain, sleep, and stress. She earned her doctorate in psychology at the University of British Columbia.
Gregory T. Carter, MD, MS
Research Panel
Chief Medical Officer, Providence St. Luke’s Rehabilitation Medical Center
Gregory Carter is a physician and researcher whose career has focused on relieving symptoms of severe neuromuscular diseases, including ALS. He co-founded neuromuscular disease centers at the University of Washington and Providence St. Peter Hospital and is a clinical professor at Washington State University’s Elson S. Floyd College of Medicine.
Jessica Tonani, MS
Research Panel
Co-founder and CEO, Verda Bio
Jessica Tonani is a biotechnology entrepreneur and co-founder of Verda Bio and Basic Jane. Her work brings together plant science, cannabinoid research, and product development. With a background in immunology, microbiology, and molecular biology, she works to advance research into cannabis and its compounds.
Drudys Ledbetter, BSN, RN
Research Panel
Pioneer of Healthcare Visibility
Nurse Executive · Author · Systems Thinker · Entrepreneur
Founder, MAC Vernet and Project Destigmatize HealTHCare
Drudys Ledbetter, BSN, RN, is a nurse, entrepreneur, author, systems thinker, and pioneer of Healthcare Visibility. She helps healthcare recognize and operationalize the factors that influence outcomes but often remain invisible across clinical practice, technology, research, education, and policy. Through speaking, research, consulting, and writing, she equips leaders to transform overlooked insights into better decisions and stronger healthcare systems. Drudys is the founder of MAC Vernet and Project Destigmatize HealTHCare and the author of Healthcare Cannot Manage What It Cannot See.
Steph Sherer
Town Hall
Founder, Executive Director, and Board President, Americans for Safe Access
Steph Sherer founded Americans for Safe Access in 2002 and has spent more than two decades advancing medical cannabis access and patient rights. Her advocacy spans local, state, federal, and international policy, with a focus on bringing patient voices into decisions about care. She returned as ASA’s Executive Director in 2024 and leads its work to integrate cannabis-based medicines into the U.S. healthcare system.
Amanda Reiman, PhD, MSW
Town Hall
Founder, Personal Plants · Social worker and public health researcher
Amanda Reiman has studied the relationship between people, cannabis, and society for 25 years. She founded Personal Plants, an education platform focused on healthy, balanced relationships with cannabis, harm reduction, and public health. She earned her PhD in Social Welfare from UC Berkeley, conducted early studies of medical cannabis patients and cannabis as a substitute for alcohol and other drugs, and taught at Berkeley for 11 years. She previously served as the Drug Policy Alliance’s in-house cannabis expert.
Washington State Department of Health
Meet the DOH panel participants
Shannon Angell
Deputy Director, Center for Drug Systems, Data, and Science
Annie Kause
Program Manager, Medical Cannabis Program
Johnny Wong
Cannabis Scientist, Medical Cannabis Program
Tholo “TJ” Johnson
Microbiologist 3, Medical Cannabis Program
Loralei Walker
Medical Cannabis Program
Bianca Rexroth
Health Services Consultant, Medical Cannabis Program
Jason Ritz
Closing Speaker
Cannabis entrepreneur, consultant, and patient advocate
Ambassador for REACH.WA
Jason Ritz is a cannabis industry entrepreneur, consultant, and advocate with extensive experience in business development, patient advocacy, and legislative reform. He was among the first class of cannabis consultants certified by the Washington State Department of Health, has judged more than 10 cannabis competitions, and has helped develop cannabis businesses and legalization efforts across the U.S. and internationally.
LOCATION
University of Washington Tacoma
William Phillips Hall
1900 Commerce Street
Tacoma, WA 98402